Back
Kura Oncology Vs. Perspective Therapeutics Industry Stock Comparison
Sell
14
KURA
Kura Oncology
Last Price:
10.83
Seasonality Move:
19.26%
Sell
30
CATX
Perspective Therapeutics
Last Price:
3.49
Seasonality Move:
34.33%
Sell
14
Kura Oncology (KURA)
is a Sell
Is Kura Oncology a Buy, Sell or Hold?
- The current Kura Oncology [KURA] share price is $10.80. The Score for KURA is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
- KURA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
30
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $3.47. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
KURA Stock Price Chart
What is Kura Oncology's stock price today?
-
The Kura Oncology share price today is $10.80
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KURA is experiencing slight buying pressure.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $3.47
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing buying pressure, which is a positive indicator for future bullish movement.
KURA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.37 | Sell |
Relative Strength Index (14 RSI): | 21.77 | Sell |
Chaikin Money Flow: | 2702856 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.7 - 18.64) | Sell |
Bollinger Bands (100): | (17.12 - 21.06) | Sell |
CATX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.06 | Sell |
Relative Strength Index (14 RSI): | 14.31 | Sell |
Chaikin Money Flow: | 5909257 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.39 - 12.93) | Sell |
Bollinger Bands (100): | (10.25 - 14.79) | Sell |
KURA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 14.86 | Sell |
20-day SMA: | 16.47 | Sell |
50-day SMA: | 17.93 | Sell |
200-day SMA: | 19.94 | Sell |
8-day EMA: | 14.13 | Sell |
20-day EMA: | 15.9 | Sell |
50-day EMA: | 17.43 | Sell |
200-day EMA: | 18.29 | Sell |
CATX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.64 | Sell |
20-day SMA: | 9.7 | Sell |
50-day SMA: | 11.58 | Sell |
200-day SMA: | 12.72 | Sell |
8-day EMA: | 6.25 | Sell |
20-day EMA: | 8.74 | Sell |
50-day EMA: | 10.88 | Sell |
200-day EMA: | 11.36 | Sell |
Kura Oncology Earnings Growth & KURA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.37 per share, and an increase next year of $0.50 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.49 per share.
Kura Oncology Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Perspective Therapeutics Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |